Skip to main content
OpenTrials

Clinical trial condition

Genital Neoplasms, Male

Explore clinical trials studying Genital Neoplasms, Male. Study availability and eligibility vary by location and protocol.

5,014 public trials 1,020 recruiting studies
Refine in advanced search Browse all conditions

Genital Neoplasms, Male trial results

Recruiting

Study of Orally Administered MOMA-313 in Participants With Advanced or Metastatic Solid Tumors

NCT06545942

Conditions
Adnexal Diseases, Advanced Solid Tumor, Breast Cancer, +36 more
Locations
  • Investigative Site #108 Goodyear, Arizona, United States
  • Investigative Site #101 La Jolla, California, United States
  • Investigative Site #111 San Francisco, California, United States
  • Investigative Site #104 Lake Mary, Florida, United States
View all 18 locations
View Trial Details
Recruiting

PROSTATE-IQ: Parallel RandOmized STudy of Personalized Apalutamide Treatment and Evaluation to Improve Quality of Life in Post-Operative Radiation With Androgen Axis Suppression. A Phase III Multi-center Study for Men With Detectable PSA After Prostatectomy for Prostate Cancer.

NCT06274047

Conditions
Androgen Axis Suppression, Genital Diseases, Genital Diseases, Male, +10 more
Locations
  • Banner MD Anderson Gilbert, Arizona, United States
  • Rush MD Anderson Chicago, Illinois, United States
  • University of Kansas Medical Center Kansas City, Kansas, United States
  • Dana-Farber Cancer Institute Boston, Massachusetts, United States
View Trial Details
Recruiting

DESTINY-PANTUMOUR04

NCT07124000

Conditions
Adenocarcinoma, Adenocarcinoma (NOS), Adnexal Diseases, +116 more
Locations
  • Research Site Birmingham, Alabama, United States
  • Research Site Bullhead City, Arizona, United States
  • Research Site Casa Grande, Arizona, United States
  • Research Site San Diego, California, United States
View all 18 locations
View Trial Details
Recruiting

A Study to Compare the Efficacy and Safety of BMS-986365 Versus the Investigator's Choice of Therapy in Participants With Metastatic Castration-resistant Prostate Cancer

NCT06764485

Conditions
Bulbo-Spinal Atrophy, X-Linked, Central Nervous System Diseases, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, +20 more
Locations
  • Central Alabama Research Birmingham, Alabama, United States
  • Banner MD Anderson Cancer Center Gilbert, Arizona, United States
  • Local Institution - 0370 Anaheim, California, United States
  • Moores Cancer Center La Jolla, California, United States
View all 281 locations
View Trial Details
Recruiting

A Study of Opevesostat (MK-5684) Versus Alternative Next-generation Hormonal Agent (NHA) in Metastatic Castration-resistant Prostate Cancer (mCRPC) Post One NHA (MK-5684-004)

NCT06136650

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • The University of Arizona Cancer Center - North Campus ( Site 0073) Tucson, Arizona, United States
  • UCLA Hematology/Oncology - Santa Monica ( Site 0044) Los Angeles, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center ( Site 0040) Orange, California, United States
  • University of California, Irvine (UCI) Health - UC Irvine Medical Center (0120) Orange, California, United States
View all 329 locations
View Trial Details
Recruiting

Fractionated Stereotactic Radiotherapy Plus Second-generation Antiandrogen for Oligometastatic Castration-resistant Prostate Cancer Patients.

NCT07717268

Conditions
Genital Diseases, Genital Diseases, Male, Genital Neoplasms, Male, +8 more
Locations
  • Hospital Universitario Miguel Servet Zaragoza, Aragon, Spain
  • Hospital Clinic de Barcelona Barcelona, Spain
  • Instituto Catalán de Oncología Hospitalet L'Hospitalet de Llobregat, Barcelona, Spain
  • Hospital Universitario Basurto Bilbao, Basque Country, Spain
View all 15 locations
View Trial Details

Related conditions